by Kelley Tracy | Mar 21, 2016 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Direct-to-Phase II SBIR Grant from the National Institutes of Health Entitled “Development of Topical Antiviral Agents for Treating Molluscum Contagiosum” Doylestown, PA. March 21,...
by Kelley Tracy | Feb 10, 2016 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Been Selected to Participate in the Spring, 2016 I-Corps Program of the National Institutes of Health Doylestown, PA. February 10, 2016- FCCDC is pleased to announce that it has been selected to participate...
by Kelley Tracy | Oct 30, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center is Mentioned in a Press Release by the University of Pennsylvania Doylestown, PA. October 30, 2015- FCCDC is pleased to announce that it has been mentioned in this press release by the University of...
by Kelley Tracy | Oct 21, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it has Registered it’s 5,000th FCCDC New Chemical Entity Since 2008 Doylestown, PA. October 21, 2015- FCCDC is pleased to announce that on Oct. 21, 2015 (Back to the Future Day!), the 5,000th FCCDC New...
by Kelley Tracy | Oct 6, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces a Research Collaboration with Portage Biotech Inc. and Biohaven Doylestown, PA. October 6, 2015- FCCDC is pleased to announce a research collaboration with Portage Biotech Inc. and Biohaven, as seen in...
by Kelley Tracy | May 20, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it is Working Together With the Wistar Institute to Discover Inhibitors of Epstein Barr Nuclear Antigen EBNA1 for the Treatment of Epstein Barr Virus-Mediated Cancers Doylestown, PA. May 20, 2015- FCCDC is pleased...
